Improving rare disease diagnosis and outcomes through screening and scientific exchange – what can be done in the Middle East


Inherited disorders and congenital malformations are a leading cause of infant mortality across the Gulf region, accounting for about 40% of infant deaths in the UAE alone.1 With about 11 million infants born each year in the Middle East and North Africa region, screening for genetic disorders is a public health priority.2,    

To read the full publication, click here